325,100 Shares in Integer Holdings Corporation $ITGR Bought by Cibc World Market Inc.

Cibc World Market Inc. purchased a new position in Integer Holdings Corporation (NYSE:ITGR) in the 2nd quarter, Holdings Channel.com reports. The fund purchased 325,100 shares of the medical equipment provider’s stock, valued at approximately $30,381,000.

Several other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in shares of Integer by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 3,886,150 shares of the medical equipment provider’s stock valued at $304,791,000 after buying an additional 14,465 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Integer by 6.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,484,396 shares of the medical equipment provider’s stock worth $130,620,000 after buying an additional 90,277 shares during the period. State Street Corp lifted its stake in shares of Integer by 3.7% in the 4th quarter. State Street Corp now owns 1,371,767 shares of the medical equipment provider’s stock valued at $107,588,000 after acquiring an additional 48,463 shares during the last quarter. Viking Global Investors LP lifted its stake in shares of Integer by 9.1% in the 2nd quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider’s stock valued at $157,889,000 after acquiring an additional 106,692 shares during the last quarter. Finally, Irenic Capital Management LP purchased a new stake in Integer during the 4th quarter valued at about $99,109,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ITGR has been the topic of a number of analyst reports. Truist Financial cut Integer from a “buy” rating to a “hold” rating and lifted their price target for the stock from $110.00 to $127.00 in a research note on Monday, August 3rd. Raymond James Financial cut shares of Integer from a “moderate buy” rating to a “hold” rating in a research report on Monday, August 3rd. Wells Fargo & Company upped their price objective on shares of Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th. Finally, Benchmark lowered shares of Integer from a “buy” rating to a “hold” rating in a report on Thursday, August 13th. One equities research analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $109.86.

Integer Stock Performance

Shares of Integer stock opened at $125.22 on Monday. Integer Holdings Corporation has a 12 month low of $62.00 and a 12 month high of $126.14. The firm has a market capitalization of $4.26 billion, a P/E ratio of 34.21, a P/E/G ratio of 2.96 and a beta of 0.61. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75. The business has a fifty day simple moving average of $104.12 and a two-hundred day simple moving average of $93.15.

Integer (NYSE:ITGR) last released its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.38 by $0.22. The firm had revenue of $464.11 million for the quarter, compared to the consensus estimate of $451.07 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company’s revenue was down 2.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.55 EPS. On average, equities analysts forecast that Integer Holdings Corporation will post 6.08 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.